Navigation Links
Considering Transplant and on Oxygen, Singer-Songwriter with Rare Lung Disease Returns to Stage Nov. 7, Pulmonary Hypertension Association Announces
Date:10/27/2013

New York, NY (PRWEB) October 27, 2013

The 1st Annual Pulmonary Hypertension Association (PHA) New York City O2 breathe Gala will take place on Thursday, November 7th at the Lighthouse at Pier 61 in New York City. Craig Melvin, MSNBC anchor and NBC News correspondent will serve as Master of Ceremonies for the event. (http://tinyurl.com/qf4seve)

“It will be an elegant event to honor the legacy of Dr. Robyn Barst, a pioneer in the field of pulmonary hypertension (PH) who passed earlier this year, and to raise funds and awareness to fight PH,” said Gina Parziale, Executive Director of PHA’s New York Tri-State Chapter, http://www.PHAssociation.org/NY-PHA. “We are grateful to Craig Melvin for donating his time to support the event,” she said.

Inspiring Performance by Pulmonary Hypertension Patient

A highlight of the evening will be a performance by 2011 AVON National and International Songwriting Competition Winner, singer/songwriter Chloe Temtchine. Mere months after her diagnosis, Ms. Temtchine will valiantly launch her "No Pressure Tour" with an intimate live performance at the event, singing while using her oxygen tank which she affectionately calls “Steve Martin.”

Last year, Ms. Temtchine's album, produced by American Grammy nominee, Greg Camp, was nearing completion when she was rushed to the emergency room due to congestive right-heart failure and diagnosed with a life-threatening pulmonary disease, Pulmonary Veno Occlusive Disease (PVOD.) PVOD is a condition which causes narrowing of the pulmonary veins and venules by fibrous tissue causing PH. Currently, lung transplantation is the only therapeutic option capable of significantly prolonging and improving the lives of patients with PH caused by PVOD.
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Federal Judicial Panel Considering Byetta Lawsuit Consolidation, Rottenstein Law Group LLP Reports
2. Stryker Hip Lawsuit News: Those Considering Filing Lawsuits Need to Heed Statutes of Limitation, Rottenstein Law Group LLP Reports
3. Newport Board Group, a National Business Advisory Firm of CEOs That Serves the Middle Market, Issues Guidance for Companies Considering a Sale in 2013
4. Long-Time-Liner® Beverly Hills advises on the key points to seek in a qualified technician for those considering the newly emerging permanent make-up trend.
5. Cosmetic Vaginal Surgeons, Dr. Miklos and Dr. Moore evaluate the preoperative perceptions and postoperative expectations of 550 patients who are considering a labiaplasty
6. When considering bariatric surgery think about bones
7. Medical Tourism: Uncharted Territory for Patients James Goldberg, Author of the American Medical Money Machine, Is Offering a New Consulting Service to Medical Patients Considering “Medical Tourism” Treatment
8. Study ties bone marrow transplant to negative sexual side effects
9. Beverly Hills Hair Transplant Doctor Unveils a New Procedure in Hair Restoration
10. US Hair Restoration Establishes a Unique and Advanced Training Program for Hair Transplant Technicians
11. Washington University and Barnes-Jewish Kidney Transplant Program Celebrates 50 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 5i Sciences, a medical technology ... of Molly Coye, M.D., M.P.H. to a role as ... authority on the market introduction of innovative technologies that ... will advise on strategies for building a successful commercial ... Dr. Coye is currently the Chief Innovation Officer ...
(Date:7/22/2014)... 2014 The Middle East Drilling fluid and ... and completion fluid market in Middle East with analysis and ... in Middle East is estimated to grow from around $560 ... CAGR of 5.7%, for the given period. , Browse through ... fluid Market report, to get an idea of the in-depth ...
(Date:7/22/2014)... Marine threats from human or natural agents ... and international criminal and piracy threats have created ... systems. Due to this the worldwide revenue of ... 2014 and is expected to reach $20.87 billion ... expected to grow at a CAGR of 8.40%. ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... tests may one day help predict survival and the course ... also called Lou Gehrig,s disease, Italian researchers report. , , ... how fast ALS is progressing are called albumin and creatinine. ... health, according to the U.S. National Library of Medicine. ...
(Date:7/22/2014)... has received a five-year, $3 million grant to ... neglect and maltreatment during childhood leave molecular marks ... life. , The Center for Biomarker Research and ... in collaboration with Duke University School of Medicine, ... by the National Institutes of Health, National Institute ...
Breaking Medicine News(10 mins):Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2
... multispecialty medical group in Southern California, announced the opening of its ... Monrovia. , ... Torrance, CA (PRWEB) December 16, 2008 ... Southern California, announced the opening of its newest medical office ...
... portal that features the latest news, facts and nutritional updates about ... acai plant and the acai berry fruit to help the general ... ... Dallas, TX (PRWEB) December 16, 2008 -- The announcement ...
... Inc.(CTI),(Nasdaq and MTA: CTIC) announced today they have ... a 50/50 owned joint venture, RIT,Oncology LLC (LLC), ... United States. In connection with the closing, ... and will receive an,additional $7.5 million in early ...
... Dec. 15 Today, the U.S. Food,and Drug Administration ... along with diet to help lower triglycerides,and LDL cholesterol, ... TRILIPIX is the first and only fibrate to ... In certain patients, treatment guidelines,recommend the combination of a ...
... Calif.) -- A secondary analysis of a large, multicenter ... fruits, vegetables and fiber and somewhat lower in fat ... of recurrence in a subgroup of early-stage breast cancer ... by approximately 31 percent. These patients typically have higher ...
... say , , MONDAY, Dec. 15 (HealthDay News) -- Men ... spread beyond the wall of the prostate gland -- ... risk of dying in half, a new study has ... much longer, the Swedish research team concluded. In fact, ...
Cached Medicine News:Health News:HealthCare Partners Opens a New Medical Office in Monrovia, CA 2Health News:AcaiBerryMD.com Explains the Real Facts About the Acai Berry Fruit 2Health News:AcaiBerryMD.com Explains the Real Facts About the Acai Berry Fruit 3Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 2Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 3Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 4Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 5Health News:(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:Diet may cut risk of breast cancer recurrence in women without hot flashes 2Health News:Diet may cut risk of breast cancer recurrence in women without hot flashes 3Health News:Radiation Plus Hormone Therapy Cuts Prostate Cancer Deaths 2Health News:Radiation Plus Hormone Therapy Cuts Prostate Cancer Deaths 3
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
(Date:7/22/2014)... ,  July 22, 2014 The ... Thomson Reuters , the world,s leading provider ... today announced Cortellis Clinical Trials Intelligence ... an industry-first milestone with the documentation of ... pharmaceutical professionals with greater and quicker access ...
(Date:7/22/2014)...  Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. ... with the Icahn School of Medicine at ... ) to utilize its proprietary information and data package ... Niemann-Pick Type C Disease (NPC), a rare disease, mostly ... license also covers other diseases and disorders relying on ...
Breaking Medicine Technology:Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
UST-675-P is our end-fire prostate transducer. Multiple frequencies provide extraordinary imaging capabilities for your diverse patient population, and the biopsy guide enables accurate and fast pros...
Super High Density 360 degree radial rectal transducer. High resolution in the near field and lower frequencies for deeper penetration make this transducer the optimal choice when scanning the anal c...
Our most versatile transducer for superficial imaging. Wide Band, Super High Density, multi-frequency transducer with superb Doppler and color flow sensitivity make this an excellent choice for breas...
... 5545 linear transducer is our high ... superficial and vascular imaging. Multiple frequencies ... sensitivity combined with our exclusive transducer ... PixelFocus to provide excellent resolution and ...
Medicine Products: